PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+11.15%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$457M
AUM Growth
+$457M
(+10%)
Cap. Flow
+$32.2M
Cap. Flow
% of AUM
7.05%
Top 10 Holdings %
Top 10 Hldgs %
38.17%
Holding
99
New
16
Increased
39
Reduced
27
Closed
16
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$18M |
| 2 |
Repligen
RGEN
|
$7.73M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$7.13M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$5.93M |
| 5 |
Protagonist Therapeutics
PTGX
|
$5.83M |
Top Sells
| 1 |
Amgen
AMGN
|
$11.2M |
| 2 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$5.13M |
| 3 |
Vericel Corp
VCEL
|
$4.71M |
| 4 |
Arrowhead Research
ARWR
|
$4.65M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
$3.98M |
Sector Composition
| 1 | Healthcare | 95.62% |
| 2 | Technology | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gossamer Bio
GOSS
$587M
| $6.39M | 1.4% |
786,870
+203,980
| +35% | +$1.66M |
|
|
NVRO
27
DELISTED
NEVRO CORP.
NVRO
| $5.93M | 1.3% |
+35,792
| New | +$5.93M |
|
|
CTLT
28
DELISTED
CATALENT, INC.
CTLT
| $5.92M | 1.29% |
54,739
-24,787
| -31% | -$2.68M |
|
|
29
Protagonist Therapeutics
PTGX
$3.62B
| $5.83M | 1.28% |
+130,000
| New | +$5.83M |
|
|
APEN
30
DELISTED
Apollo Endosurgery, Inc.
APEN
| $5.6M | 1.22% |
691,214
+616,214
| +822% | +$4.99M |
|
31
BioCryst Pharmaceuticals
BCRX
$1.74B
| $5.57M | 1.22% |
351,961
+107,281
| +44% | +$1.7M |
|
32
Ionis Pharmaceuticals
IONS
$9.64B
| $5.44M | 1.19% |
136,380
+30,583
| +29% | +$1.22M |
|
33
InfuSystem Holdings
INFU
$215M
| $5.23M | 1.14% |
251,567
-27,266
| -10% | -$567K |
|
34
Axogen
AXGN
$718M
| $5.14M | 1.12% |
237,652
+26,053
| +12% | +$563K |
|
35
Immunic
IMUX
$79.4M
| $5.08M | 1.11% |
414,087
+12,869
| +3% | +$158K |
|
36
Idexx Laboratories
IDXX
$50.7B
| $4.84M | 1.06% |
7,667
+35
| +0.5% | +$22.1K |
|
37
Codexis
CDXS
$218M
| $4.67M | 1.02% |
206,067
+106,067
| +106% | +$2.4M |
|
|
SPNE
38
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $4.62M | 1.01% |
225,000
+34,253
| +18% | +$703K |
|
39
MannKind Corp
MNKD
$1.69B
| $4.39M | 0.96% |
805,047
+405,047
| +101% | +$2.21M |
|
40
Maravai LifeSciences
MRVI
$341M
| $3.76M | 0.82% |
90,000
-22,500
| -20% | -$939K |
|
41
Madrigal Pharmaceuticals
MDGL
$9.7B
| $3.55M | 0.78% |
36,393
-3,328
| -8% | -$324K |
|
42
BridgeBio Pharma
BBIO
$9.91B
| $3.53M | 0.77% |
57,978
-7,196
| -11% | -$439K |
|
43
Outset Medical
OM
$245M
| $3.52M | 0.77% |
4,689
+356
| +8% | +$267K |
|
44
Kodiak Sciences
KOD
$453M
| $3.41M | 0.75% |
36,702
+3,654
| +11% | +$340K |
|
45
Harvard Bioscience
HBIO
$21.1M
| $3.35M | 0.73% |
+402,367
| New | +$3.35M |
|
46
Supernus Pharmaceuticals
SUPN
$2.52B
| $3.09M | 0.68% |
+100,415
| New | +$3.09M |
|
47
Inotiv
NOTV
$54.3M
| $3.07M | 0.67% |
115,000
+40,000
| +53% | +$1.07M |
|
48
Sutro Biopharma
STRO
$85.6M
| $3.04M | 0.66% |
163,389
-39,307
| -19% | -$731K |
|
49
Health Catalyst
HCAT
$228M
| $2.8M | 0.61% |
50,515
-14,759
| -23% | -$819K |
|
50
89bio
ETNB
$1.37B
| $2.54M | 0.56% |
135,848
+33,685
| +33% | +$630K |
|